s Corrigendum to: GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma

The author requested to add a co-author after the publication of the original article [1]. In this correction, the author has been added in the article entitled “GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma” in the journal “Current Drug Targets” 2021; 22(13), 1485-1495. Details of the error and a correction are provided here. The original editorial can be found online at 10.2174/1389450122666210204203950 We regret any errors and apologize to the readers. Original: Sitansu S. Nanda¹, Md Imran Hossain¹, Heongkyu Ju² and Dong Kee Yi¹,* ¹Department of Chemistry, Myongji University, Yongin, 03674, South Korea; ²Department of Physics, Gachon University, Seongnam-si, Gyeonggi-do, South Korea Corrected: Sitansu S. Nanda¹, Md Imran Hossain¹, Heongkyu Ju², Georgia C. Papaefthymiou³ and Dong Kee Yi¹,* ¹Department of Chemistry, Myongji University, Yongin, 03674, South Korea; ²Department of Physics, Gachon University, Seongnam-si, Gyeonggi-do, South Korea ³Department of Physics, Villanova University, Villanova, Pennsylvania19085, USA